Skip to main content

Advertisement

SpringerLink
Log in

A review of UVA-mediated photosensitivity disorders

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

A number of skin conditions are characterised by photosensitivity to UVA. Some of these are exclusively UVA-mediated conditions, while others include UVA in the action spectrum which also include UVB and/or visible light. This review aims to describe this diverse range of conditions for non-dermatologist scientists with an interest in this topic. As such, clinical details, including treatments, are brief and succinct. Recent advances in understanding the pathogenesis of these conditions is highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L. M. Yap, P. Foley, R. Crouch et al., Chronic actinic dermatitis: a retrospective analysis of 44 cases referred to an Australian photobiology clinic, Australas. J. Dermatol., 2003, 44, 256–62.

    PubMed  Google Scholar 

  2. H. Menage, J. S. Ross, P. G. Norris et al., Contact and photocontact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen, Br. J. Dermatol., 1995, 132, 543–7.

    CAS  PubMed  Google Scholar 

  3. M. Trakatelli, S. Charalampidis, L. B. Novakovic et al., Photodermatoses with onset in the elderly, Br. J. Dermatol., 2009, 161(Suppl 3) 69–77.

    PubMed  Google Scholar 

  4. Y. Ma, Z. Lu, Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study, J. Dermatol. Treat., 2010, 21, 171–7.

    Google Scholar 

  5. M. A. Thomson, D. G. Stewart, H. M. Lewis, Chronic actinic dermatitis treated with mycophenolate mofetil, Br. J. Dermatol., 2005, 152, 784–6.

    CAS  PubMed  Google Scholar 

  6. A. L. Chew, S. J. Bashir, J. L. Hawk et al., Contact and photocontact sensitization in chronic actinic dermatitis: a changing picture, Contact Dermatitis, 2010, 62, 42–6.

    CAS  PubMed  Google Scholar 

  7. V. K. Sharma, G. Sethuraman, Parthenium dermatitis, Dermatitis, 2007, 18, 183–90.

    PubMed  Google Scholar 

  8. P. E. Beattie, R. S. Dawe, S. H. Ibbotson et al., Characteristics and prognosis of idiopathic solar urticaria: a cohort of 87 cases, Arch. Dermatol., 2003, 139, 1149–54.

    PubMed  Google Scholar 

  9. P. Calzavara-Pinton, R. Sala, M. Venturini et al., Local angioedema following sun exposures: a report of five cases, Int. Arch. Allergy Immunol., 2010, 153, 315–20.

    PubMed  Google Scholar 

  10. R. F. Rose, M. Bhushan, C. M. King et al., Solar angioedema: an uncommonly recognized condition?, Photodermatol., Photoimmunol. Photomed., 2005, 21, 226–8.

    CAS  PubMed  Google Scholar 

  11. J. L. Hawk, R. A. Eady, A. V. Challoner et al., Elevated blood histamine levels and mast cell degranulation in solar urticaria, Br. J. Clin. Pharmacol., 1980, 9, 183–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. V. Leenutaphong, E. Holzle, G. Plewig, Pathogenesis and classification of solar urticaria: a new concept, J. Am. Acad. Dermatol., 1989, 21, 237–40.

    CAS  PubMed  Google Scholar 

  13. M. Kojima, T. Horiko, Y. Nakamura et al., Solar urticaria. The relationship of photoallergen and action spectrum, Arch. Dermatol., 1986, 122, 550–5.

    CAS  PubMed  Google Scholar 

  14. G. Monfrecola, E. Masturzo, A. M. Riccardo et al., Solar urticaria: a report on 57 cases, Am. J. Contact Dermatitis, 2000, 11, 89–94.

    CAS  Google Scholar 

  15. C. T. Jong, A. Y. Finlay, A. D. Pearse et al., The quality of life of 790 patients with photodermatoses, Br. J. Dermatol., 2008, 159, 192–7.

    CAS  PubMed  Google Scholar 

  16. S. C. Jordan, M. Toyoda, A. A. Vo, Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation, Expert Rev. Clin. Immunol., 2011, 7, 341–8.

    CAS  PubMed  Google Scholar 

  17. A. M. Marsland, Autoimmunity and complement in the pathogenesis of chronic urticaria, Curr. Allergy Asthma Rep., 2006, 6, 265–9.

    CAS  PubMed  Google Scholar 

  18. G. Krishnaswamy, J. Kelley, D. Johnson et al., The human mast cell: functions in physiology and disease, Front. Biosci., 2001, 6, D1109–27.

    CAS  PubMed  Google Scholar 

  19. M. Llamas-Velasco, D. D. Argila, C. Eguren et al., Solar urticaria unresponsive to intravenous immunoglobulins, Photodermatol., Photoimmunol. Photomed., 2011, 27, 53–4.

    PubMed  Google Scholar 

  20. L. Maksimovic, G. Fremont, M. Jeanmougin et al., Solar urticaria successfully treated with intravenous immunoglobulins, Dermatology, 2009, 218, 252–4.

    PubMed  Google Scholar 

  21. R. Hughes, C. Cusack, G. M. Murphy et al., Solar urticaria successfully treated with intravenous immunoglobulin, Clin. Exp. Dermatol., 2009, 34, e660.

    CAS  PubMed  Google Scholar 

  22. O. Guzelbey, E. Ardelean, M. Magerl et al., Successful treatment of solar urticaria with anti-immunoglobulin E therapy, Allergy, 2008, 63, 1563–5.

    CAS  PubMed  Google Scholar 

  23. K. H. Waibel, D. A. Reese, R. G. Hamilton et al., Partial improvement of solar urticaria after omalizumab, J. Allergy Clin. Immunol., 2010, 125, 490–1.

    CAS  PubMed  Google Scholar 

  24. A. K. Haylett, Z. Nie, M. Brownrigg et al., Systemic photoprotection in solar urticaria with alpha-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-alpha-MSH, Br. J. Dermatol., 2011, 164, 407–14.

    CAS  PubMed  Google Scholar 

  25. T. S. Sonnex, J. L. Hawk, Hydroa vacciniforme: a review of ten cases, Br. J. Dermatol., 1988, 118, 101–8.

    CAS  PubMed  Google Scholar 

  26. G. Gupta, I. Man, D. Kemmett, Hydroa vacciniforme: A clinical and follow-up study of 17 cases, J Am Acad Dermatol, 2000, 42, 208–13.

    CAS  PubMed  Google Scholar 

  27. K. H. Cho, S. H. Lee, C. W. Kim et al., Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases, Br. J. Dermatol., 2004, 151, 372–80.

    PubMed  Google Scholar 

  28. K. Iwatsuki, M. Satoh, T. Yamamoto et al., Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders, Arch. Dermatol., 2006, 142, 587–95.

    CAS  PubMed  Google Scholar 

  29. L. Verneuil, S. Gouarin, F. Comoz et al., Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up, Br. J. Dermatol., 2010, 163, 174–82.

    CAS  PubMed  Google Scholar 

  30. M. Magana, P. Sangueza, J Gil-Beristain et al., Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma, J. Am. Acad. Dermatol., 1998, 38, 574–9.

    CAS  PubMed  Google Scholar 

  31. T. Oono, J. Arata, T. Masuda et al., Coexistence of hydroa vacciniforme and malignant lymphoma, Arch. Dermatol., 1986, 122, 1306–9.

    CAS  PubMed  Google Scholar 

  32. V. Blackwell, J. M. McGregor, J. L. Hawk, Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A, Clin. Exp. Dermatol., 1998, 23, 73–6.

    CAS  PubMed  Google Scholar 

  33. F. Durbec, Z. Reguiai, F. Leonard et al., Efficacy of omega-3 Polyunsaturated Fatty Acids for the Treatment of Refractory Hydroa Vacciniforme, Pediatr. Dermatol., 2011 10.1111/j.1525-1470.2011.01486.x.

    Google Scholar 

  34. L. E. Rhodes, S. I. White, Dietary fish oil as a photoprotective agent in hydroa vacciniforme, Br. J. Dermatol., 1998, 138, 173–8.

    CAS  PubMed  Google Scholar 

  35. R. S. Dawe, P. Collins, J. Ferguson et al., Actinic prurigo and HLA-DR4, J. Invest. Dermatol., 1997, 108, 233–4.

    CAS  PubMed  Google Scholar 

  36. Hd. Menage, R. W. Vaughan, C. S. Baker et al., HLA-DR4 may determine expression of actinic prurigo in British patients, J. Invest. Dermatol., 1996, 106, 362–7.

    Google Scholar 

  37. A. Suarez, M. C. Valbuena, M. Rey et al., Association of HLA subtype DRB10407 in Colombian patients with actinic prurigo, Photodermatol., Photoimmunol. Photomed., 2006, 22, 55–8.

    CAS  PubMed  Google Scholar 

  38. M. C. Wiseman, P. H. Orr, S. M. Macdonald et al., Actinic prurigo: clinical features and HLA associations in a Canadian Inuit population, J. Am. Acad. Dermatol., 2001, 44, 952–6.

    CAS  PubMed  Google Scholar 

  39. R. M. Fusaro, J. A. Johnson, Topical photoprotection for hereditary polymorphic light eruption of American Indians, J. Am. Acad. Dermatol., 1991, 24, 744–6.

    CAS  PubMed  Google Scholar 

  40. P. Collins, J. Ferguson, Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses, Br. J. Dermatol., 1995, 132, 956–63.

    CAS  PubMed  Google Scholar 

  41. P. M. Farr, B. L. Diffey, Treatment of actinic prurigo with PUVA: mechanism of action, Br. J. Dermatol., 1989, 120, 411–8.

    CAS  PubMed  Google Scholar 

  42. C. R. Lovell, J. L. Hawk, C. D. Calnan et al., Thalidomide in actinic prurigo, Br. J. Dermatol., 1983, 108, 467–71.

    CAS  PubMed  Google Scholar 

  43. B. Torres-Alvarez, J. P. Castanedo-Cazares, B. Moncada, Pentoxifylline in the treatment of actinic prurigo. A preliminary report of 10 patients, Dermatology, 2004, 208, 198–201.

    CAS  PubMed  Google Scholar 

  44. M. M. Duran, C. P. Ordonez, J. C. Prieto et al., Treatment of actinic prurigo in Chimila Indians, Int. J. Dermatol., 1996, 35, 413–6.

    CAS  PubMed  Google Scholar 

  45. D. Lestarini, L. S. Khoo, C. L. Goh, The clinical features and management of actinic prurigo: a retrospective study, Photodermatol., Photoimmunol. Photomed., 1999, 15, 183–7.

    CAS  PubMed  Google Scholar 

  46. J. V. Ortiz-Castillo, A. Boto-de-los-Bueis, R. De-Lucas-Laguna et al., [Topical cyclosporine in the treatment of ocular actinic prurigo], Arch. Soc. Esp. Oftalmol., 2006, 81, 661–4.

    CAS  PubMed  Google Scholar 

  47. K. R. Stein, N. S. Scheinfeld, Drug-induced photoallergic and phototoxic reactions, Expert Opin. Drug Saf., 2007, 6, 431–43.

    CAS  PubMed  Google Scholar 

  48. C. Arlett, L. Earl, J. Ferguson et al., British Photodermatology Group Workshop. Predictive in vitro methods for identifying photosensitizing drugs: a report, Br. J. Dermatol., 1995, 132, 271–4.

    CAS  PubMed  Google Scholar 

  49. B. M. Verdel, P. C. Souverein, R. H. Meyboom et al., Risk of drug-induced photosensitivity: focus on spectroscopic and molecular characteristics, Pharmacoepidemiol. Drug Saf., 2009, 18, 602–9.

    CAS  PubMed  Google Scholar 

  50. R. S. Dawe, S. H. Ibbotson, J. B. Sanderson et al., A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity, Br. J. Dermatol., 2003, 149, 1232–41.

    CAS  PubMed  Google Scholar 

  51. C. K. Svensson, E. W. Cowen, A. A. Gaspari, Cutaneous drug reactions, Pharmacol. Rev., 2001, 53, 357–79.

    CAS  PubMed  Google Scholar 

  52. I. Andreu, C. Mayorga, M. A. Miranda, Generation of reactive intermediates in photoallergic dermatitis, Curr. Opin. Allergy Clin. Immunol., 2010, 10, 303–8.

    CAS  PubMed  Google Scholar 

  53. B. E. Johnson, J. Ferguson, Drug and chemical photosensitivity, Semin. Dermatol., 1990, 9, 39–46.

    CAS  PubMed  Google Scholar 

  54. D. W. Smith, L. Lemli, J. M. Opitz, A Newly Recognized Syndrome of Multiple Congenital Anomalies, J. Pediatr., 1964, 64, 210–7.

    CAS  PubMed  Google Scholar 

  55. A. V. Anstey, A. Ryan, L. E. Rhodes et al., Characterization of photosensitivity in the Smith-Lemli-Opitz syndrome: a new congenital photosensitivity syndrome, Br. J. Dermatol., 1999, 141, 406–14.

    CAS  PubMed  Google Scholar 

  56. A. V. Anstey, C. R. Taylor, Photosensitivity in the Smith-Lemli-Opitz syndrome: the US experience of a new congenital photosensitivity syndrome, J. Am. Acad. Dermatol., 1999, 41, 121–3.

    CAS  PubMed  Google Scholar 

  57. C. R. Charman, A. Ryan, R. M. Tyrrell et al., Photosensitivity associated with the Smith-Lemli-Opitz syndrome, Br. J. Dermatol., 1998, 138, 885–8.

    CAS  PubMed  Google Scholar 

  58. C. F. Chignell, B. M. Kukielczak, R. H. Sik et al., Ultraviolet A sensitivity in Smith-Lemli-Opitz syndrome: Possible involvement of cholesta-5,7,9(11)-trien-3 beta-ol, Free Radical Biol. Med., 2006, 41, 339–46.

    CAS  Google Scholar 

  59. M. Kovarova, C. A. Wassif, S. Odom et al., Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness, J. Exp. Med., 2006, 203, 1161–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. P. G. Norris, J. L. Hawk, Polymorphic light eruption, Photodermatol., Photoimmunol. Photomed, 1990, 7, 186–91.

    CAS  PubMed  Google Scholar 

  61. A. S. Janssens, S. Pavel, J. J. Out-Luiting et al., Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption, Br. J. Dermatol., 2005, 152, 1268–74.

    CAS  PubMed  Google Scholar 

  62. A. S. Janssens, S. Pavel, C. P. Tensen et al., Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption, Exp. Dermatol., 2009, 18, 212–7.

    CAS  PubMed  Google Scholar 

  63. R. A. Palmer, J. L. Hawk, A. R. Young et al., The effect of solar-simulated radiation on the elicitation phase of contact hypersensitivity does not differ between controls and patients with polymorphic light eruption, J. Invest. Dermatol., 2005, 124, 1308–12.

    CAS  PubMed  Google Scholar 

  64. W. Kolgen, H. Van Weelden, S. Den Hengst et al., CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption, J. Invest. Dermatol., 1999, 113, 4–10.

    CAS  PubMed  Google Scholar 

  65. R. M. Fusaro, J. A. Johnson, Hereditary polymorphic light eruption of American Indians: occurrence in non-Indians with polymorphic light eruption, J. Am. Acad. Dermatol., 1996, 34, 612–7.

    CAS  PubMed  Google Scholar 

  66. J. M. McGregor, S. Grabczynska, R. Vaughan et al., Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo, J. Invest. Dermatol., 2000, 115, 471–6.

    CAS  PubMed  Google Scholar 

  67. T. P. Millard, V. Bataille, H. Snieder et al., The heritability of polymorphic light eruption, J. Invest. Dermatol., 2000, 115, 467–70.

    CAS  PubMed  Google Scholar 

  68. C. M. Proby, C. S. Baker, O. Morton et al., New broad-spectrum sunscreen for polymorphic light eruption, Lancet, 1993, 341, 1347–8.

    CAS  PubMed  Google Scholar 

  69. D. C. Patel, G. J. Bellaney, P. T. Seed et al., Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial, Br. J. Dermatol., 2000, 143, 828–31.

    CAS  PubMed  Google Scholar 

  70. D. Bilsland, S. A. George, N. K. Gibbs et al., A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption, Br. J. Dermatol., 1993, 129, 708–12.

    CAS  PubMed  Google Scholar 

  71. G. M. Murphy, J. L. Hawk, I. A. Magnus, Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring, Br. J. Dermatol., 1987, 116, 379–86.

    CAS  PubMed  Google Scholar 

  72. P. G. Norris, J. L. Hawk, Successful treatment of severe polymorphous light eruption with azathioprine, Arch. Dermatol., 1989, 125, 1377–9.

    CAS  PubMed  Google Scholar 

  73. O. Lasa, I. Trebol, J. Gardeazabal et al., Prophylactic short-term use of cyclosporin in refractory polymorphic light eruption, J. Eur. Acad. Dermatol. Venereol., 2004, 18, 747–8.

    CAS  PubMed  Google Scholar 

  74. G. Kavli, G. Volden, Phytophotodermatitis, Photodermatolology, 1984, 1, 65–75.

    CAS  Google Scholar 

  75. E. A Knudsen, S. Kroon, In vitro and in vivo phototoxicity of furocoumarin-containing plants, Clin. Exp. Dermatol., 1988, 13, 92–6.

    CAS  PubMed  Google Scholar 

  76. P. Wynn, S. Bell, Phytophotodermatitis in grounds operatives, Occup. Med., 2005, 55, 393–5.

    Google Scholar 

  77. L. Lutchman, V. Inyang, D. Hodgkinson, Phytophotodermatitis associated with parsnip picking, J. Accid. Emerg. Med., 1999, 16, 453–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. A. M. Wagner, J. J. Wu, R. C. Hansen et al., Bullous phytophotodermatitis associated with high natural concentrations of furanocoumarins in limes, Am. J. Contact Dermatitis, 2002, 13, 10–4.

    Google Scholar 

  79. A. C. Kung, M. B. Stephens, T. Darling, Phytophotodermatitis: bulla formation and hyperpigmentation during spring break, Mil. Med,, 2009, 174, 657–61.

    PubMed  Google Scholar 

  80. K. Carlsen, K. Weismann, Phytophotodermatitis in 19 children admitted to hospital and their differential diagnoses: Child abuse and herpes simplex virus infection, J. Am. Acad. Dermatol., 2007, 57, S88–91.

    PubMed  Google Scholar 

  81. J. C. Chan, P. J. Sullivan, M. J. O’Sullivan et al., Full thickness burn caused by exposure to giant hogweed: delayed presentation, histological features and surgical management, J. Plast., Reconstr. Aesthetic Surg., 2011, 64, 128–30.

    Google Scholar 

  82. K. Foering, R. Goreshi, R. Klein et al., Prevalence of self-report photosensitivity in cutaneous lupus erythematosus, J. Am. Acad. Dermatol., 2011 10.1016/j.jaad.2010.12.006.

    Google Scholar 

  83. A. Kuhn, M. Sonntag, D. Richter-Hintz et al., Phototesting in lupus erythematosus: a 15-year experience, J. Am. Acad. Dermatol., 2001, 45, 86–95.

    CAS  PubMed  Google Scholar 

  84. P. Lehmann, B. Homey, Clinic and pathophysiology of photosensitivity in lupus erythematosus, Autoimmun. Rev., 2009, 8, 456–61.

    CAS  PubMed  Google Scholar 

  85. N. Scheinfeld, V. A. Deleo, Photosensitivity in lupus erythematosus, Photodermatol., Photoimmunol. Photomed., 2004, 20, 272–9.

    PubMed  Google Scholar 

  86. A. Kuhn, A. Wozniacka, J. C. Szepietowski et al., Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol, J. Invest. Dermatol., 2011, 131, 1622–30.

    CAS  PubMed  Google Scholar 

  87. A. Kuhn, F. Ochsendorf, G. Bonsmann, Treatment of cutaneous lupus erythematosus, Lupus, 2010, 19, 1125–36.

    CAS  PubMed  Google Scholar 

  88. H. W. Walling, R. D. Sontheimer, Cutaneous lupus erythematosus: issues in diagnosis and treatment, Am. J. Clin. Dermatol., 2009, 10, 365–81.

    PubMed  Google Scholar 

  89. C. J. Sanders, H. Y. Lam, C. A. Bruijnzeel-Koomen et al., UV hardening therapy: a novel intervention in patients with photosensitive cutaneous lupus erythematosus, J. Am. Acad. Dermatol., 2006, 54, 479–86.

    PubMed  Google Scholar 

  90. H. McGrath, Jr., Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus, Clin. Exp. Rheumatol., 1994, 12, 129–35.

    PubMed  Google Scholar 

  91. H. McGrath, P. Martinez-Osuna, F. A. Lee, Ultraviolet-A1 (340–400 nm) irradiation therapy in systemic lupus erythematosus, Lupus, 1996, 5, 269–74.

    CAS  PubMed  Google Scholar 

  92. A. Kuhn, K. Gensch, M. Haust et al., Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study, J. Am. Acad. Dermatol., 2011, 64, 37–48.

    CAS  PubMed  Google Scholar 

  93. S. Lautenschlager, H. C. Wulf, M. R. Pittelkow, Photoprotection, Lancet, 2007, 370, 528–37.

    CAS  PubMed  Google Scholar 

  94. J. Geng, W. Tang, X. Wan et al., Photoprotection of bacterial-derived melanin against ultraviolet A-induced cell death and its potential application as an active sunscreen, J. Eur. Acad. Dermatol. Venereol., 2008, 22, 852–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiff and Vale University Health Board, Heath Park, Cardiff, UK, CF14 4XN

    E. Smith

  2. Aneurin Bevan Health Board, Academic Dermatology, St Woolos Hospital, Stow Hill, Newport, UK, NP20 4SZ

    F. Kiss & A. V. Anstey

  3. Department of Dermatology, University of Debrecen, Medical and Health Science Centre, Hungary

    F. Kiss

  4. Department of Wound Healing and Dermatology, School of Medicine, Cardiff University, Heath Park, Cardiff, UK, CF14 4XN

    R. M. Porter & A. V. Anstey

Authors
  1. E. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. M. Porter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. V. Anstey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. V. Anstey.

Additional information

Contribution to the themed issue on the biology of UVA.

RMP is currently a freelance lecturer and science writer based in Cardiff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, E., Kiss, F., Porter, R.M. et al. A review of UVA-mediated photosensitivity disorders. Photochem Photobiol Sci 11, 199–206 (2012). https://doi.org/10.1039/c1pp05191a

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/c1pp05191a

Search

Navigation